174 related articles for article (PubMed ID: 37788736)
1. Dynamical hallmarks of cancer: Phenotypic switching in melanoma and epithelial-mesenchymal plasticity.
Jain P; Pillai M; Duddu AS; Somarelli JA; Goyal Y; Jolly MK
Semin Cancer Biol; 2023 Nov; 96():48-63. PubMed ID: 37788736
[TBL] [Abstract][Full Text] [Related]
2. Stochastic population dynamics of cancer stemness and adaptive response to therapies.
Jain P; Duddu AS; Jolly MK
Essays Biochem; 2022 Sep; 66(4):387-398. PubMed ID: 36073715
[TBL] [Abstract][Full Text] [Related]
3. Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis.
Pillai M; Rajaram G; Thakur P; Agarwal N; Muralidharan S; Ray A; Barbhaya D; Somarelli JA; Jolly MK
Front Oncol; 2022; 12():913803. PubMed ID: 36003764
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of Epithelial-Mesenchymal Plasticity: What Have Single-Cell Investigations Elucidated So Far?
Subhadarshini S; Markus J; Sahoo S; Jolly MK
ACS Omega; 2023 Apr; 8(13):11665-11673. PubMed ID: 37033874
[TBL] [Abstract][Full Text] [Related]
5. Cancer cells exhibit clonal diversity in phenotypic plasticity.
Mathis RA; Sokol ES; Gupta PB
Open Biol; 2017 Feb; 7(2):. PubMed ID: 28202626
[TBL] [Abstract][Full Text] [Related]
6. Population Dynamics of Epithelial-Mesenchymal Heterogeneity in Cancer Cells.
Jain P; Bhatia S; Thompson EW; Jolly MK
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327538
[TBL] [Abstract][Full Text] [Related]
7. Interconnected high-dimensional landscapes of epithelial-mesenchymal plasticity and stemness in cancer.
Sahoo S; Ashraf B; Duddu AS; Biddle A; Jolly MK
Clin Exp Metastasis; 2022 Apr; 39(2):279-290. PubMed ID: 34993766
[TBL] [Abstract][Full Text] [Related]
8. Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?
Jolly MK; Tripathi SC; Somarelli JA; Hanash SM; Levine H
Mol Oncol; 2017 Jul; 11(7):739-754. PubMed ID: 28548388
[TBL] [Abstract][Full Text] [Related]
9. Modeling differentiation-state transitions linked to therapeutic escape in triple-negative breast cancer.
Chapman MP; Risom T; Aswani AJ; Langer EM; Sears RC; Tomlin CJ
PLoS Comput Biol; 2019 Mar; 15(3):e1006840. PubMed ID: 30856168
[TBL] [Abstract][Full Text] [Related]
10. Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.
Hossain SM; Eccles MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675114
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Biophysical Changes during Human Melanoma Plasticity.
Lionetti MC; Fumagalli MR; La Porta CAM
Cells Tissues Organs; 2024; 213(2):120-132. PubMed ID: 36509081
[TBL] [Abstract][Full Text] [Related]
12. Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity.
Subhadarshini S; Sahoo S; Debnath S; Somarelli JA; Jolly MK
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37678920
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-mesenchymal-like transition events in melanoma.
Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins.
Mooney SM; Jolly MK; Levine H; Kulkarni P
Asian J Androl; 2016; 18(5):704-10. PubMed ID: 27427552
[TBL] [Abstract][Full Text] [Related]
15. Landscape of epithelial-mesenchymal plasticity as an emergent property of coordinated teams in regulatory networks.
Hari K; Ullanat V; Balasubramanian A; Gopalan A; Jolly MK
Elife; 2022 Oct; 11():. PubMed ID: 36269057
[TBL] [Abstract][Full Text] [Related]
16. Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer.
Jindal R; Nanda A; Pillai M; Ware KE; Singh D; Sehgal M; Armstrong AJ; Somarelli JA; Jolly MK
Comput Struct Biotechnol J; 2023; 21():1498-1509. PubMed ID: 36851919
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma.
Vig N; Mackenzie IC; Biddle A
J Oral Pathol Med; 2015 Oct; 44(9):649-55. PubMed ID: 25594908
[TBL] [Abstract][Full Text] [Related]
18. Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals.
Fakhri S; Moradi SZ; Abbaszadeh F; Faraji F; Amirian R; Sinha D; McMahon EG; Bishayee A
Cancer Metastasis Rev; 2024 Mar; 43(1):261-292. PubMed ID: 38169011
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
20. EMT and MET: necessary or permissive for metastasis?
Jolly MK; Ware KE; Gilja S; Somarelli JA; Levine H
Mol Oncol; 2017 Jul; 11(7):755-769. PubMed ID: 28548345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
